JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: Reboxetine (also known as PNU 155950E; Trade name: Edronax) is a selective norepinephrine reuptake inhibitor with Ki of 8.2 nM and antidepressant activity. Reboxetine dose-dependently and completely inhibits 3H-dopamine uptake to the human norepinephrine transporters (hNET) with Ki value of 11 nM in Madin–Darby canine kidney (MDCK) cells. Reboxetine dose-dependently and potently inhibits locus coeruleus neuronal firing in rats with ED50 of 191 ug/kg. Reboxetine inhibition of the locus coeruleus neurons is reversible by the alpha2 antagonist piperoxan (1.5 mg/kg, IV). Reboxetine dose-dependently reverses reserpine-induced blepharospasm and hypothermia in the mouse.
References: Biol Psychiatry. 2000 May 1; 47(9):818-29; J Clin Psychiatry. 2002 Jan; 63(1):31-7; J Clin Psychiatry. 1999 Jun; 60(6):400-6.
Related CAS: 71620-89-8 (free)
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!